How Dollars Dictated the Hasty Development of Vioxxhttp://articles.mercola.com/sites/articles/archive/2006/03/25/how-dollars-dictated-the-hasty-development-of-vioxx.aspxIn the most recent Vioxx liability trial, David Anstice, Merck's former president of human health, testified that Merck rushed development of Vioxx because it was concerned it would lose profits if it did not beat Pfizer's similar drug Celebrex to marketenCommunityServer 2008.5 SP1 (Build: 31106.3070)